Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000930413-09-000677
Filing Date
2009-02-05
Accepted
2009-02-05 16:23:40
Documents
7
Period of Report
2008-10-31

Document Format Files

Seq Description Document Type Size
1 c56492_10k.htm 10-K 1020405
2 GRAPHIC img1.gif GRAPHIC 7349
3 c56492_ex21.htm EX-21 1516
4 c56492_ex31-1.htm EX-31.1 5450
5 c56492_ex31-2.htm EX-31.2 5439
6 c56492_ex32-1.htm EX-32.1 2220
7 c56492_ex32-2.htm EX-32.2 2211
  Complete submission text file 0000930413-09-000677.txt   1049115
Mailing Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309
Business Address 5360 NORTHWEST 35TH AVENUE FT. LAUDERDALE FL 33309 954-486-4590
Synovics Pharmaceuticals (Filer) CIK: 0001030839 (see all company filings)

EIN.: 860760991 | State of Incorp.: NV | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 000-22011 | Film No.: 09573310
SIC: 2833 Medicinal Chemicals & Botanical Products